Lifestyle
- Regular exercise
- Adequate hydration
ALP · AP · Alkaline Phosphatase
Alkaline Phosphatase measures the enzyme activity involved in dephosphorylation processes in the liver and bones.
Reference ranges can vary based on age and sex, with higher levels typically seen in children and adolescents due to bone growth.
Alkaline Phosphatase (ALP) is an enzyme found in various tissues throughout the body, with high concentrations in the liver, bones, kidneys, and bile ducts. It plays a crucial role in the process of breaking down proteins and is involved in dephosphorylation, which is essential for various metabolic processes. Clinically, ALP is an important biomarker for assessing liver and bone health. Elevated levels can indicate liver disease, bile duct obstruction, or bone disorders, while low levels may suggest malnutrition or certain genetic conditions. In the context of athletic performance and biohacking, ALP levels can reflect bone turnover and liver function, which are important for recovery and overall metabolic health. However, the relevance of ALP in longevity is less clear, as it primarily serves as a marker for acute or chronic conditions rather than long-term health outcomes. Researchers have found that ALP levels can be influenced by factors such as age, sex, and certain medications. Fasting is generally not required for ALP testing, but levels can be affected by recent meals, particularly those high in fat. Time of day does not significantly impact ALP levels, making it a convenient marker for routine health assessments.
Klinische Bedeutung
Elevated ALP levels often indicate liver disease, bile duct obstruction, or bone disorders such as Paget's disease. Low ALP levels may suggest malnutrition, hypothyroidism, or genetic conditions such as hypophosphatasia.
Progressively rising ALP levels suggest worsening liver or bone conditions. Retesting is recommended every 4-6 weeks if levels are outside the normal range.
Decreasing ALP levels may indicate improvement in liver or bone health or resolution of an underlying condition.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any new supplementation, especially if underlying health conditions are present.
ALP levels can vary throughout the day; consistent timing is recommended for follow-up tests.
Testing Frequency
Annually for routine health checks, more frequently if monitoring a known condition.
May affect
Current research suggests that while alkaline phosphatase (ALP) is a prognostic marker in metastatic castration-resistant prostate cancer, reference ranges and optimal targets for ALP levels in this context remain debated. Researchers have not yet established the full impact of different therapies on ALP dynamics or the confounding effects of other biomarkers. Additionally, clinical questions regarding the integration of ALP with other prognostic indicators to tailor treatment strategies effectively remain unanswered.
1,228
Total Citations
20
Human/RCT
2.5
Avg. Influence
2024
Latest
Van Hoof V O & De Broe M E · Critical reviews in clinical laboratory sciences · 1994
This study provided insights into alkaline phosphatase isoenzyme patterns and their clinical significance. Researchers found that interpreting these patterns can offer valuable diagnostic information, especially in liver and bone diseases.
Key findings
Researchers reviewed various biomarkers for predicting the severity of acute pancreatitis. They found that C-reactive protein remains the gold standard, while other markers like procalcitonin and interleukin-6 are not routinely used due to low accuracy and high costs.
This review focused on recent developments in fluorescence strategies for detecting alkaline phosphatase (ALP). Researchers observed that abnormal ALP levels are associated with many diseases, and innovative detection methods are needed for precision medicine. The study discussed future trends in ALP detection technology.
Researchers found that alkaline phosphatase (AP) may serve as a potential biomarker for stroke, examining its biological role and clinical evidence linking AP to stroke-related conditions. They discussed the implications for using AP isoenzymes in stroke diagnostics and treatment.
This study analyzed bone marrow involvement in small cell lung cancer patients and its correlation with routine laboratory variables. Researchers found significant differences in serum levels of various biomarkers, including alkaline phosphatase, between patients with and without bone marrow metastasis. The study concluded that routine bone marrow examinations may not be necessary for staging small cell lung cancer.
Researchers reviewed the use of alkaline phosphatase (ALP) as a biomarker in clinical practice and biomedical research. They found that abnormal ALP levels are significant for diagnosing liver dysfunction, bone diseases, and other conditions.
Researchers discussed the role of interleukin-17 in acute pancreatitis. They found that IL-17 contributes to pancreatic tissue damage and may be a target for therapeutic strategies to alleviate the condition.
This review discussed the role of alkaline phosphatase (ALP) in childhood rickets, noting that elevated ALP levels are a marker for diagnosis. Researchers found that ALP is crucial for differentiating rickets from other similar disorders.
This study examined the clinical significance of varying serum alkaline phosphatase levels. Researchers observed that increased ALP levels can indicate a range of pathological conditions across multiple organs. The study also noted that decreased ALP levels hold diagnostic value.
Research publications about Alkalische Phosphatase over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer